ScreenerHero

AVCR Avricore Health Inc.

TSXV · CA · Healthcare · Diagnostics & Research · avricore.com
0.0600CAD0.00%Mkt Cap: 5.52M $P/E: —

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$244.79BUSDP/E 36.7
DHR
Danaher Corporation
$153.60BUSDP/E 38.9
NTRA
Natera, Inc.
$57.02BUSD
LONN
Lonza Group AG
$46.01BUSDP/E 38.3
A
Agilent Technologies, Inc.
$47.67BUSDP/E 33.4
WAT
Waters Corporation
$42.81BUSDP/E 110.4
IQV
IQVIA Holdings Inc.
$42.48BUSDP/E 32.1
ILMN
Illumina, Inc.
$40.43BUSDP/E 50.0
IDXX
IDEXX Laboratories, Inc.
$39.97BUSDP/E 35.6
MTD
Mettler-Toledo International Inc.
$30.73BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.30BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.06BUSDP/E 24.1
GH
Guardant Health, Inc.
$22.59BUSD
RVTY
Revvity, Inc.
$17.14BUSDP/E 73.5
MEDP
Medpace Holdings, Inc.
$16.87BUSDP/E 35.5
ERF
Eurofins Scientific SE
$14.23BUSDP/E 26.6
CRL
Charles River Laboratories International, Inc.
$14.34BUSD
ICLR
ICON Public Limited Company
$12.66BUSDP/E 172.7
BIM
bioMérieux S.A.
$10.35BUSDP/E 20.7
QGEN
Qiagen N.V.
$9.25BUSDP/E 22.7

Key Statistics

Company
Market Cap5.52M USD
Enterprise Value5.31M USD
Revenue (TTM)140.58K USD
Gross Profit173.54K USD
Net Income (TTM)-1.35M USD
Revenue/Share0.0020 CAD
Last Price0.0600 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDiagnostics & Research
ISINCA0545211090
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.62
EV/Revenue37.77
P/S42.55
P/B7.22
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.045027% of range0.1000
52W High0.1000 CAD
52W Low0.0450 CAD
Profitability
Gross Margin44.63%
Oper. Margin-292.01%
EBITDA Margin0.00%
Profit Margin-348.16%
ROE-477.14%
ROA-330.08%
Growth
Revenue Growth170.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-575.28K USD
CapEx (TTM)83.29K USD
FCF Margin-288.35%
FCF Yield-7.34%
Net Debt-671.86K USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity—
Current Ratio8.24
Quick Ratio7.40
Book Value/Sh0.0090 CAD
Cash/Share0.0070 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 21, 2016
Splits
Last Split1:4
Split DateNov 21, 2016
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.126.37M
Float114.66M
Insiders6.66%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float0.00%
Short % Out.0.00%
Shares Short2.66K
Short (prev mo.)8.87K
Technical
SMA 500.0606 (-1.0%)
SMA 2000.0632 (-5.1%)
Beta0.40
S&P 52W Chg16.45%
Avg Vol (30d)33.01K
Avg Vol (10d)18.50K
Technical Indicators
RSI (14)48.8
MACD-0.0008
MACD Signal-0.0003
MACD Hist.-0.0006
BB Upper0.0761 CAD
BB Middle0.0630 CAD
BB Lower0.0499 CAD
BB Width41.71%
ATR (14)0.0034 CAD
Vol Ratio (20d)0.12x